A randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating the safety, efficacy, and pharmacokinetic profile of TP04HN106 treatment in patients with amyotrophic lateral sclerosis

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: f8506894e90e26b59521d3ce8bc1b1714c697fb1
First added on: Mar 01, 2025